97 related articles for article (PubMed ID: 2418882)
1. Calmodulin antagonists stimulate LDL receptor synthesis in human skin fibroblasts.
Filipovic I; Buddecke E
Biochim Biophys Acta; 1986 Mar; 876(1):124-32. PubMed ID: 2418882
[TBL] [Abstract][Full Text] [Related]
2. Calcium channel blockers stimulate LDL receptor synthesis in human skin fibroblasts.
Filipovic I; Buddecke E
Biochem Biophys Res Commun; 1986 May; 136(3):845-50. PubMed ID: 3718500
[TBL] [Abstract][Full Text] [Related]
3. Calmodulin antagonists increase the amount of mRNA for the low-density-lipoprotein receptor in skin fibroblasts.
Eckardt H; Filipovic I; Hasilik A; Buddecke E
Biochem J; 1988 Jun; 252(3):889-92. PubMed ID: 3421929
[TBL] [Abstract][Full Text] [Related]
4. Calmodulin antagonists suppress cholesterol synthesis by inhibiting sterol delta 24 reductase.
Filipovic I; Buddecke E
Lipids; 1987 Apr; 22(4):261-5. PubMed ID: 3037232
[TBL] [Abstract][Full Text] [Related]
5. Regulation of synthesis and cell content of the low-density-lipoprotein receptor protein in cultured fibroblasts from normal and familial hypercholesterolaemic subjects.
Knight BL; Patel DD; Soutar AK
Eur J Biochem; 1987 Feb; 163(1):189-96. PubMed ID: 3816797
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticoid-stimulated biosynthesis of low density lipoprotein receptor in cultured fibroblasts.
Filipovic I; Buddecke E
J Clin Chem Clin Biochem; 1985 Jun; 23(6):331-6. PubMed ID: 2991417
[TBL] [Abstract][Full Text] [Related]
7. N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, a calmodulin antagonist, reverses the inhibitory effect of insulin on lipolysis due to dibutyryl cyclic AMP.
Goko H; Matsuoka A
Diabetes Res Clin Pract; 1993 Mar; 19(3):177-81. PubMed ID: 7686456
[TBL] [Abstract][Full Text] [Related]
8. The role of calmodulin in the responses to adrenocorticotropin of plasma membranes from adrenal cells.
Papadopoulos V; Widmaier EP; Hall PF
Endocrinology; 1990 May; 126(5):2465-73. PubMed ID: 2158426
[TBL] [Abstract][Full Text] [Related]
9. Cyclic AMP stimulates efflux of intracellular sterol from cholesterol-loaded cells.
Hokland BM; Slotte JP; Bierman EL; Oram JF
J Biol Chem; 1993 Dec; 268(34):25343-9. PubMed ID: 7503979
[TBL] [Abstract][Full Text] [Related]
10. Calmodulin antagonists stimulate renin release from isolated rat glomeruli.
Kawamura M; Inagami T
Endocrinology; 1983 May; 112(5):1857-9. PubMed ID: 6187563
[TBL] [Abstract][Full Text] [Related]
11. Agents which increase cyclic AMP have diverse effects on low-density-lipoprotein-receptor function in human vascular smooth-muscle cells and skin fibroblasts.
Middleton A; Middleton B
Biochem J; 1990 May; 267(3):607-14. PubMed ID: 1692702
[TBL] [Abstract][Full Text] [Related]
12. Calmodulin antagonists chlorpromazine and W-7 inhibit exogenous cholesterol esterification and sphingomyelinase activity in human skin fibroblast cultures. Similarities between drug-induced and Niemann-Pick type C lipidoses.
Masson M; Spezzatti B; Chapman J; Battisti C; Baumann N
J Neurosci Res; 1992 Jan; 31(1):84-8. PubMed ID: 1613824
[TBL] [Abstract][Full Text] [Related]
13. Regulation of HMG-CoA reductase, apoprotein-B and LDL receptor gene expression by the hypocholesterolemic drugs simvastatin and ciprofibrate in Hep G2, human and rat hepatocytes.
Qin W; Infante J; Wang SR; Infante R
Biochim Biophys Acta; 1992 Jul; 1127(1):57-66. PubMed ID: 1627634
[TBL] [Abstract][Full Text] [Related]
14. Activation of bovine rod outer segment phosphatidylinositol-4,5-bisphosphate phospholipase C by calmodulin antagonists does not depend on calmodulin.
Gehm BD; Pinke RM; Laquerre S; Chafouleas JG; Schultz DA; Pepperl DJ; McConnell DG
Biochemistry; 1991 Nov; 30(47):11302-6. PubMed ID: 1659898
[TBL] [Abstract][Full Text] [Related]
15. Cyclic AMP stimulates the synthesis and function of the low-density lipoprotein receptor in human vascular smooth-muscle cells and fibroblasts.
Middleton B; Middleton A
Biochem J; 1992 Mar; 282 ( Pt 3)(Pt 3):853-61. PubMed ID: 1313231
[TBL] [Abstract][Full Text] [Related]
16. Effect of anticalmodulin and antitubulin on LDL-receptor synthesis in aortic smooth muscle cells cultured in vitro.
Mehta U; Kaul D
Indian J Biochem Biophys; 1990 Aug; 27(4):251-3. PubMed ID: 2286392
[TBL] [Abstract][Full Text] [Related]
17. Calmodulin antagonists enhance calcium binding to calmodulin.
Inagaki M; Tanaka T; Hidaka H
Pharmacology; 1983; 27(3):125-9. PubMed ID: 6622516
[TBL] [Abstract][Full Text] [Related]
18. Effects of calmodulin antagonists on hormone release and cyclic AMP levels in GH3 pituitary cells.
Sletholt K; Haug E; Gordeladze J; Sand O; Gautvik KM
Acta Physiol Scand; 1987 Jun; 130(2):333-43. PubMed ID: 3037857
[TBL] [Abstract][Full Text] [Related]
19. Action of low-density lipoprotein and compactin, a competitive inhibitor of 3-hydroxy-3-methylglutaryl-CoA reductase, on the synthesis of dolichol-linked oligosaccharides and low-density-lipoprotein receptor in human skin fibroblasts.
Filipovic I; Menzel B
Biochem J; 1981 May; 196(2):625-8. PubMed ID: 6274316
[TBL] [Abstract][Full Text] [Related]
20. Direct interaction of calmodulin antagonists with Ca2+/calmodulin-dependent cyclic nucleotide phosphodiesterase.
Itoh H; Hidaka H
J Biochem; 1984 Dec; 96(6):1721-6. PubMed ID: 6099352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
